Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Chelsea Therapeutics: There Are Safer Rebound Plays
Seeking Alpha
Wednesday, November 11, 2009 - 8:53am
tags:
Chelsea Therapeutics, BioDelivery Sciences, Titan
Avanir shares jump on new Zenvia data
Fierce Biotech
Wednesday, November 11, 2009 - 8:24am
tags:
Zenvia, Avanir, MS, multiple sclerosis
Lexicon Pharmaceuticals: Stuck in Phase II?
Seeking Alpha
Wednesday, November 11, 2009 - 8:22am
tags:
Lexicon Pharmaceuticals, drug trials
Study confirms clot risks with anti-anemia drugs
Reuters
Wednesday, November 11, 2009 - 8:20am
tags:
anemia, cancer, Amgen, Aranesp, Epogen, Procrit, JNJ
Glaxo’s Swine Flu Shot Wins U.S. Approval After Delay
Bloomberg
Wednesday, November 11, 2009 - 8:19am
tags:
GSK, swine flu, H1N1, vaccines, FDA
Cramer Jeers J&J, Applauds Abbott
CNBC
Tuesday, November 10, 2009 - 8:40pm
tags:
JNJ, Abbott Laboratories
Did Sequenom Insiders Sell Stock Before Data Corruption Was Revealed?
BNET Pharma
Tuesday, November 10, 2009 - 7:39pm
tags:
Sequenom
Justice eyes marketing at J&J, Forest
Fierce Pharma
Tuesday, November 10, 2009 - 7:27pm
tags:
JNJ, Forest Labs, DOJ
Teva gets FDA approval for generic Prevacid
Yahoo/AP
Tuesday, November 10, 2009 - 7:26pm
tags:
generics, Prevacid, heartburn, Teva Pharmaceuticals
Sanofi Promises Regeneron $980 Million For Research
Forbes
Tuesday, November 10, 2009 - 7:24pm
tags:
Regeneron, R&D, Sanofi
Enzon Beats, Announces Sell-off
Yahoo/Zacks.com
Tuesday, November 10, 2009 - 7:23pm
tags:
Enzon, earnings, Merck, OSI Pharmaceuticals
Fighting The Flu Vaccine Critics
CNBC
Tuesday, November 10, 2009 - 7:22pm
tags:
Flu, vaccines, H1N1
Celgene in ASH Abstract Spotlight
TheStreet.com
Tuesday, November 10, 2009 - 10:34am
tags:
Celgene, ASH, Revlimid
GTC cuts 45 workers, lines up retention bonuses for execs
Bizjournals.com
Tuesday, November 10, 2009 - 10:23am
tags:
GTC Biotherapeutics, layoffs
Is Dr. Reddy's Laboratories Ready to Run?
Seeking Alpha
Tuesday, November 10, 2009 - 10:00am
tags:
Dr Reddy's, India
Teva says it wants to add 3 more patents to suit against Moment and Sandoz over Copaxone
Yahoo/AP
Tuesday, November 10, 2009 - 9:54am
tags:
Teva Pharmaceuticals, Sandoz, Copaxone, Momenta, lawsuits, MS, multiple sclerosis
Pfizer's Cutbacks Reflect Difficulties Facing Big Pharma
Seeking Alpha
Tuesday, November 10, 2009 - 9:17am
tags:
Pfizer, Big Pharma, reorganization
Courts Consolidate Dozens of Cases Against Bayer Over Yaz
BNET Pharma
Tuesday, November 10, 2009 - 9:01am
tags:
Bayer, oral contraceptives, Yaz, lawsuits
Bristol-Myers Squibb signs development deal for rheumatoid arthritis drug with Alder Biopharma
Yahoo/AP
Tuesday, November 10, 2009 - 8:59am
tags:
Alder Biopharma, Bristol-Myers Squibb, rheumatoid arthritis
The Real Price of Big Pharma's Huge Fines
Seeking Alpha
Tuesday, November 10, 2009 - 8:52am
tags:
Big Pharma, Pfizer, Bristol-Myers Squibb, Eli Lilly, Schering Plough

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.